ArticleJournal for immunotherapy of cancer2024

Bendamustine-rituximab elicits dual tumoricidal and immunomodulatory responses via cGAS-STING activation in diffuse large B-cell lymphoma.

Ruipei Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.